The gastrointestinal microbiota can affect the event of RA as a result of proximal intestinal immunomodulatory cells, which might be found in certain spots in the intestine. The latest therapeutic method of RA authorised through the FDA and EMA consists of the use of JAKi. These molecules are divided into https://www.directivepublications.org/journal-of-arthritis-and-rheumatology/